Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Henry Schein, Inc. (Nasdaq: HSIC) announced the passing of Dr. E. Dianne Rekow, a Board member since 2014 and a leader in digital dentistry. Recognized for her contributions to the field, Dr. Rekow served on the Strategic Advisory Committee and was a prominent figure in aesthetic and restorative dentistry. Her extensive academic background included roles at King's College London and NYU, along with over 100 publications and several patents. This loss may impact the company’s strategic direction given her expertise in digital solutions for dental practices.
Summary not available.
Henry Schein reported record second-quarter net sales of $3.0 billion, a 2.1% increase from the previous year. GAAP diluted EPS rose to $1.16 from $1.10 in Q2 2021. The company affirmed its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91, indicating a growth of 7% to 10% over 2021. However, sales growth expectations were adjusted to 3% to 6% due to a strong dollar and declining demand for COVID-related products. Global Medical sales increased 10.3%, while Global Dental sales saw a 3.1% decrease.
Henry Schein has appointed Mark Hillebrandt as Vice President and Chief Digital Revenue Officer, focusing on e-commerce growth as part of the company’s 2022-2024 “BOLD+1” Strategic Plan. Hillebrandt will lead a new Digital Revenue Team aimed at enhancing online customer engagement and digital transactions. His role will support the advancement of Henry Schein's e-commerce tools, thereby improving customer experience and expanding the sales team's capabilities. Hillebrandt brings nearly 15 years of industry experience, previously holding leadership roles at Amazon and KaVo Kerr.
Henry Schein, Inc. (NASDAQ: HSIC) announced the appointments of Trinh Clark as Chief Global Customer Experience Officer and Leigh Benowitz as Chief Global Digital Transformation Officer. These appointments are part of the strategic implementation of the 2022-2024 BOLD+1 plan, aimed at enhancing customer experience and accelerating digital technology adoption. Clark will lead a new Global Customer Experience Organization, while Benowitz will focus on digital commerce initiatives. Both executives bring substantial experience to their roles, aligning with the company's goal of improving operational success for healthcare providers.
Henry Schein, the largest provider of health care solutions to dental and medical practitioners, will release its second-quarter 2022 financial results on August 2, 2022, before market opening. A live webcast of the earnings call will begin at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the call through the company's website. Henry Schein continues to serve over 1 million customers globally, offering a vast range of health care solutions.
Arc Health sponsors a luncheon at the National Press Club to honor Dr. Mary McLeod Bethune's legacy and promote health equity. The event features keynote speaker Mayor Jereleen Hollimon-Miller and includes a panel of notable guests discussing preventive health awareness. The panelists, including Rev. Dr. Johnnie Green Jr. and Karen Huger, will address health disparities and the importance of preventive services. CEO Paul Adams emphasizes the need for improved healthcare in underserved communities. Arc Health and Medpod demonstrate virtual preventive health solutions during the event.
Henry Schein, Inc. (Nasdaq: HSIC) has acquired Condor Dental Research Company SA, expanding its dental distribution in Switzerland. This complete acquisition from MCCB II Holding is projected to have a neutral impact on HSIC's 2022 diluted earnings per share and be accretive thereafter. Condor Dental, established in 1978 with 2021 sales of approximately $18 million, specializes in dental consumables and lab installations. The integration of Condor Dental aims to enhance services and expand geographic reach for Henry Schein in the Swiss market.
Henry Schein Cares Foundation announces the appointment of Maureen Knott as President, succeeding Steve W. Kess, who becomes President Emeritus. Ms. Knott, a 35-year veteran of the company, aims to enhance access to care and spearhead initiatives to innovate health care systems. The Foundation focuses on wellness, access to care, disaster response, and supports health care professionals. Under her leadership, it has raised over $2 million for various health initiatives. The Foundation is committed to building a healthier world.
Henry Schein (Nasdaq: HSIC) announced an agreement to acquire Condor Dental Research Company SA, enhancing its presence in the Swiss dental distribution market. Condor, established in 1978, reported $18 million in sales in 2021, primarily from dental consumables. The acquisition is expected to be neutral to diluted earnings per share in 2022 and accretive thereafter. This strategic move aligns with Henry Schein's commitment to expand its offerings and improve services in the dental sector across Europe.